Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2018 May 29;128(7):3199. doi: 10.1172/JCI122301

ATP11B mediates platinum resistance in ovarian cancer

Myrthala Moreno-Smith, JB Halder, Paul S Meltzer, Tamas A Gonda, Lingegowda S Mangala, Rajesha Rupaimoole, Chunhua Lu, Archana S Nagaraja, Kshipra M Gharpure, Yu Kang, Cristian Rodriguez-Aguayo, Pablo E Vivas-Mejia, Behrouz Zand, Rosemarie Schmandt, Hua Wang, Robert R Langley, Nicholas B Jennings, Cristina Ivan, Jeremy E Coffin, Guillermo N Armaiz, Justin Bottsford-Miller, Sang Bae Kim, Margaret S Halleck, Mary JC Hendrix, William Bornman, Menashe Bar-Eli, Ju-Seog Lee, Zahid H Siddik, Gabriel Lopez-Berestein, Anil K Sood
PMCID: PMC6025990  PMID: 29809169

Original citation: J Clin Invest. 2013;123(5):2119–2130. https://doi.org/10.1172/JCI65425

Citation for this expression of concern: J Clin Invest. 2018;128(7):3199. https://doi.org/10.1172/JCI122301

The Editors recently became aware that Figure 3B appears to use a set of images that were previously published in a 2009 Clinical Cancer Research paper with different sample labels (doi: 10.1158/1078-0432.CCR-08-2306). Additionally, the empty liposome and control siRNA PCNA–stained panels appear to be the same. The Editorial Board is pursuing further investigation of this matter, and we will inform our readers of the outcome when the investigation is complete.

Version 1. 05/29/2018

Electronic publication

Version 2. 07/02/2018

Print issue publication

Footnotes

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES